000			01887nam a2200397 a 4500
001			EBC1204055
003			MiAaPQ
005			20240120140113.0
006			m o d |
007			cr cn|||||||||
008			130605s2013 njuad sb 001 0 eng d
010			_z 2013005181
020			_z9781118312063
020			_z9781118312056
020			_z9781118312155 (cloth)
020			_a9781118312131 (electronic bk.)
035			_a(MiAaPQ)EBC1204055
035			_a(Au-PeEL)EBL1204055
035			_a(CaPaEBR)ebr10713652
035			_a(OCoLC)827010652
040			_aMiAaPQ _cMiAaPQ _dMiAaPQ
050		4	_aRJ560 _b.P43 2013
245	0	0	_aPediatric drug development _h[electronic resource] : _bconcepts and applications / _ceditors, Andrew E. Mulberg ... [et al.].
250			_a2nd ed.
260			_aHoboken, N.J. : _bWiley, _c2013.
300			_axiv, 610 p. : _bill. (some col.)
504			_aIncludes bibliographical references and index.
505	0		_apt. I. Past, present, and future of pediatric drug development -- pt. II. Ethical underpinnings -- pt. III. Regulatory guidelines for pediatric drug development -- pt. IV. Preclinical safety assessment -- pt. V. Pharmacological principles in pediatric drug development -- pt. VI. Clinical trial operations -- pt. VII. Clinical trial operations and good clinical trials -- pt. VIII. Clinical efficacy and safety endpoints -- pt. IX. Formulation, chemistry and manufacturing controls.
533			_aElectronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
650		0	_aPediatric pharmacology.
650		0	_aDrug development.
655		4	_aElectronic books.
700	1		_aMulberg, Andrew E.
710	2		_aProQuest (Firm)
856	4	0	_uhttps://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=1204055 _zClick to View
999			_c96866 _d96866